It has been reported that increased expression of PTPRM was negatively correlated with the progression of colorectal adenoma-carcinoma, small intestinal neuroendocrine tumors and breast cancer11–13, while the single-nucleotide polymorphisms of the PTPRM suggested it could play an oncogenic role in lung cancer14. This evidence concerns the gene PTPRM and carcinoma.